ALANNA TEMME

LMH STRATEGIC SOLUTIONS · Washington, DC · registered since 2024

Registered · LDAActive

Send proposal →Contact →Claim this profile →

At a glance

Registered since

2024

Senate LDA system

Clients

last 3 years

Filings

2 agencies contacted

Activity

filings by quarter

Works on

Health Issues 13 Pharmacy 11 Medicare/Medicaid 4

Background

Government experience

Legislative Director

U.S. Representative Jon Porter

Disclosed on LD-2 filings

Career

LMH STRATEGIC SOLUTIONS

Washington, DC

2024 - present

Specific issues

General Medicare and Medicaid Issues.

Medicare/Medicaid · 2024 Q3

Prescription drug payment reform. Drug Pricing and Access. Pharmaceutical Supply Chain. Pharmacy Benefit Managers.

Pharmacy · 2024 Q3

Access for inpatient gene therapies. Monitor newborn screening issues. H.R.2666 - MVP Act.

Health Issues · 2024 Q3

Health programs impacting MDMA. H.R.1691 - Ensuring Patient Access to Critical Breakthrough Products Act of 2023, Ethylene Oxide (EtO), TCET.

Health Issues · 2024 Q3

Issues related to the implementation of H.R.5547/S.476 - Maintaining Investments in New Innovation Act and H.R.7384 - Creating Hope Reauthorization Act of 2024.

Health Issues · 2024 Q3

General healthcare issues impacting GSK. H.R.7085 - BIOSECURE Act. H.R.830 - HELP Copays Act. H.R.5378 - Lower Costs, More Transparency Act. S.1542 - DRUG Act.

Health Issues · 2024 Q3